Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy

Microbiology and Immunology

Volumn 41, Issue 1, 1997, Pages 7-12

  Gotoh, Akira ^a   Kawakami, Yoshiyuki ^b   Akahane, Takayuki ^c   Akamatsu, Taiji ^d   Shimizu, Toshiki ^a   Kiyosawa, Kendo ^a   Katsuyama, Tsutomu ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c Central Clinical Laboratories   (Japan)

^d SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Eradication therapy; Helicobacter pylori; Susceptibility

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG EFFICACY; DRUG SCREENING; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION;

HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0031054509     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01166.x     Document Type: Article

References (24)

1. Akamatsu, T., Ota, H., Shimizu, T., Matsuzawa, K., Fujimori, Y., Nakamura, N., Kiyosawa, K., and Katsuyama, T. 1995. Histochemical study of Helicobacter pylori and surface mucous gel layer in various gastric lesions. Acta Histochem. Cytochem. 28: 181-185.
2. Axon, A.T.R. 1991. Helicobacter pylori therapy: effect on peptic ulcer disease. J. Gastroenterol. Hepatol. 6: 131-137.
3. Bazzoli, F., Zagari, R.M., Fossi, S., Pozzato, P., Alampi, G., Simoni, P., Sottili, S., Roda, A., and Roda, E. 1994. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 6: 773-777.
4. Becx, M.C.J.M., Janssen, A.J.H.M., Clasener, H.A.L., and De Koning, R.W. 1990. Metronidazole-resistant Helicobacter pylori. Lancet i: 539-540.
5. Chiba, N., Rao, B.V., Rademaker, J.W., and Hunt, R.H. 1992. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am. J. Gastroenterol. 87: 1716-1727.
6. Cooreman, M.P., Krausgrill, P., and Hengels, K.J. 1993. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob. Agents Chemother. 37: 1506-1509.
7. Glupczynski, Y., and Burette, A. 1990. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am. J. Gastroenterol. 85: 1545-1551.
8. Glupczynski, Y., Burette, A., De Koster, E., Nyst, J.F., Deltenre, M., Cadranel, S., Bourdeaux, L., and De Vos, D. 1990. Metronidazole resistance in Helicobacter pylori. Lancet 335: 976-977.
9. Goodwin, C.S. 1988. Duodenal ulcer, Campylobacter pylori, and the "leaking roof concept. Lancet ii: 1467-1469.
10. Goodwin, C.S., Blake, P., and Blincow, E. 1986. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J. Antimicrob. Chemother. 17: 309-314.
11. Graham, D.Y., and Börsch, G.M. 1990. The who's and when's of therapy for Helicobacter pylori. Am. J. Gastroenterol. 85: 1552-1555.
12. Graham, D.Y., Lew, G.M., Klein, P.D., Evans, D.G., Evans, D.J., Saeed, Z.A., and Malaty, H.M. 1992. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann. Intern. Med. 116: 705-708.
13. Jerris, R.C. 1995. Bacteriology, Helicobacter, p. 492-498. In Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., and Yolken, R.H. (eds), Manual of clinical microbiology, 6th ed, American Society for Microbiology, Washington D.C.
14. Lambert, T., Mégraud, F., Gerbaud, G., and Courvalin, P. 1986. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob. Agents Chemother. 30: 510-511.
15. Marshall, B.J., Goodwin, C.S., Warren, J.R., Murray, R., Blincow, E.D., Blackbourn, S.J., Phillips, M., Waters, T.E., and Sanderson, C.R. 1988. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet ii: 1439-1442.
16. Marshall, B.J., and Warren, J.R. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i: 1311-1314.
17. McNulty, C.A.M., Dent, J.C., Ford, G.A., and Wilkinson, S.P. 1988. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J. Antimicrob. Chemother. 22: 729-738.
18. McNulty, C.A.M., Dent, J., and Wise, R. 1985. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob. Agents Chemother. 28: 837-838.
19. Queiroz, D.M.M., Coimbra, R.S., Mendes, E.N., Rocha, G.A., Alves, V.M., Oliverira, C.A., and Lima, G.F. 1993. Metronidazole-resistant Helicobacter pylori in a developing country. Am. J. Gastroenterol. 88: 322-323.
20. Rautelin, H., Seppälä, K., Renkonen, O., Vainio, U., and Kosunen, T.U. 1992. Role of metronidazole resistance in therapy of Helicobacterpylori infection. Antimicrob. Agents Chemother. 36: 163-166.
21. Rauws, E.A., and Tytgat, G.N. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335: 1233-1235.
22. Shimizu, T., Ota, H., Kawakami, Y., Gotoh, A., Akamatsu, T., and Katsuyama, T. 1996. Immunohistochemical detection of Helicobacter pylori in the surface mucous gel layer and its clinicopathological significance. Helicobacter (in press).
23. Sung, J.Y., Chung, S.C.S., Ling, T.K.W., Yung, M.Y., Leung, V.K.S., Ng, E.K.W., Li, M.K.K., Cheng, A.F.B., and Li, A.K.C. 1995. Antibacterial treatment of gastric ulcer associated with Helicobacter pylori. New Engl. J. Med. 332: 139-142.
24. Warren, J.R., and Marshall, B.J. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i: 1273-1275.